Related Experiment Video
Updated: May 15, 2026

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
Published on: December 11, 2017
Left ventricular pacing in persistent left superior vena cava: a case series and potential application
Swee-Chong Seow1, Michael F Agbayani, Toon-Wei Lim
1Cardiology Department, National University Health System, 1 E Kent Ridge Road, Level 9 NUHS Tower Block, Singapore 119228, Singapore. Swee_Chong_Seow@nuhs.edu.sg
Implanting pacemaker leads in patients with persistent left superior vena cava (PLSVC) can be challenging. This study shows a simple, safe method using standard leads in left ventricular epicardial veins.
Area of Science:
- Cardiology
- Medical Devices
- Electrophysiology
Background:
- Persistent left superior vena cava (PLSVC) affects 0.3-2% of the population.
- Pacemaker implantation in PLSVC patients presents unique technical challenges.
- Traditional methods involve manipulating leads through the coronary sinus into the right ventricle.
Observation:
- This case series describes pacemaker implantation in three patients with PLSVC and bradycardia.
- Left ventricular (LV) epicardial veins were identified using contrast injection in the coronary sinus.
- Standard passive tined pacing leads were successfully guided into LV epicardial veins using hand-shaped stylets.
Findings:
- The novel approach required no specialized equipment.
- No procedural complications were observed.
- Chronic ventricular capture thresholds at 6 months were favorable (1.0 mV@ 0.4 ms).
Implications:
- Implanting standard leads into LV epicardial veins is a safe and effective alternative for PLSVC patients.
- This technique simplifies pacemaker implantation compared to traditional RV lead placement.
- Further clinical trials are warranted to confirm long-term efficacy and safety.
Related Concept Videos
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy

